Global Endoscopic Ultrasound Needles Market Size By Type (Aspiration Needles (EUS-FNA), Biopsy Needles (EUS-FNB)), By Application (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forec...

The Global Endoscopic Ultrasound (EUS) Needles Market was valued at USD 235 million in 2023 and is projected to reach USD 462 million by 2031, growing at a CAGR of 8.8% during the forecast period (2023–2031). The rising prevalence of gastrointestinal (GI) diseases, increasing demand for minimally invasive diagnostic procedures, and continuous technological advancements in endoscopic equipment are major factors propelling market growth. EUS needles play a vital role in acquiring high-precision tissue samples for diagnosing cancers and other diseases, especially in the pancreas, liver, and lymph nodes, enhancing their demand globally.

Drivers:

1. Rising Prevalence of GI and Pancreatic Cancers

The growing incidence of digestive tract malignancies and pancreatic diseases globally has significantly driven the demand for EUS-guided fine needle aspiration (FNA) and fine needle biopsy (FNB). The high diagnostic accuracy offered by EUS needles further accelerates their adoption in oncology.

2. Preference for Minimally Invasive Procedures

Healthcare providers and patients increasingly prefer procedures that offer reduced recovery times, lower complications, and improved outcomes. EUS-guided interventions meet these needs by offering precision-guided diagnosis and treatment with minimal invasiveness.

3. Advancements in Needle Design and Materials

Recent innovations such as echogenic needles for enhanced visibility, flexible tip designs, and the development of hybrid needles for both aspiration and biopsy are driving the adoption of advanced EUS needles in clinical settings.

Restraints:

1. High Cost of Endoscopic Procedures

Despite the benefits, the high cost associated with endoscopic ultrasound procedures and the equipment required, including specialized needles, may limit accessibility in low- and middle-income regions.

2. Limited Expertise and Training Availability

The successful operation of EUS and interpretation of results require skilled professionals. The shortage of adequately trained gastroenterologists and endosonographers in some regions poses a barrier to wider adoption.

Opportunity:

1. Growing Demand in Emerging Economies

Asia-Pacific and Latin America represent untapped potential due to increasing healthcare investments, improving diagnostic infrastructure, and rising awareness of early cancer detection.

2. Expansion of Indications Beyond Oncology

As research expands the applications of EUS needles to non-oncological indications—such as cyst drainage, infection diagnosis, and autoimmune conditions—the market is likely to witness diversified demand.

Market by System Type Insights:

Based on system type, Fine Needle Biopsy (FNB) accounted for the largest share in 2023. The FNB needles offer superior core tissue sample retrieval, enhancing diagnostic accuracy, particularly in oncology. Their ability to combine diagnostic and therapeutic interventions in one session is driving demand. Fine Needle Aspiration (FNA) remains significant, particularly in cytological diagnostics, and is expected to see steady growth.

Market by End-use Insights:

In terms of end-use, Hospitals and Specialty Clinics dominated the market in 2023, accounting for over 60% of the global revenue. The availability of advanced endoscopic infrastructure and trained personnel makes these settings ideal for performing complex EUS procedures. Ambulatory Surgical Centers (ASCs) are expected to witness the fastest growth due to the rising trend of outpatient diagnostics, driven by lower costs and shorter patient turnaround times.

Market by Regional Insights:

North America led the global market in 2023, attributed to high diagnostic awareness, strong presence of key market players, and advanced healthcare infrastructure. Meanwhile, Asia-Pacific is anticipated to register the fastest growth during the forecast period, spurred by increasing healthcare spending, growing prevalence of GI disorders, and rapid technological adoption in countries like China, India, and Japan.

Competitive Scenario:

Key players in the Global Endoscopic Ultrasound Needles Market include:

Olympus Corporation

Cook Medical

Boston Scientific Corporation

CONMED Corporation

Medi-Globe GmbH

ACE Medical Devices

Sterylab S.R.L.

These companies are investing in R&D, launching next-generation biopsy needles, and engaging in strategic partnerships to strengthen their market presence. For example, in 2023, Boston Scientific launched a new generation of core biopsy needles with enhanced maneuverability and ultrasound visibility.

Scope of Work – Global Endoscopic Ultrasound Needles Market

Report Metric Details

Market Size (2023) USD 235 million

Projected Market Size (2031) USD 462 million

CAGR (2023–2031) 8.8%

Market Segments By System Type (FNA, FNB), By End-use

Growth Drivers Rising cancer prevalence, minimally invasive diagnostics, needle innovations

Opportunities Emerging markets, expanding indications beyond oncology

Key Market Developments:

2023: Olympus launched its latest echogenic biopsy needle with improved visibility and sampling efficiency.

2023: Cook Medical announced strategic partnerships with major hospitals across Asia to expand the use of EUS-guided FNB procedures.

2024: Boston Scientific introduced its third-generation Expect™ FNB needle designed for enhanced tissue acquisition and diagnostic yield.

FAQs:

1) What is the current market size of the Global Endoscopic Ultrasound Needles Market?

The market was valued at USD 235 million in 2023.

2) What is the major growth driver of the Global Endoscopic Ultrasound Needles Market?

The primary growth driver is the rising prevalence of gastrointestinal and pancreatic cancers combined with increasing demand for minimally invasive diagnostic procedures.

3) Which is the largest region during the forecast period in the Global Endoscopic Ultrasound Needles Market?

North America held the largest market share in 2023 and is expected to maintain its dominance.

4) Which segment accounted for the largest market share in the Global Endoscopic Ultrasound Needles Market?

The Fine Needle Biopsy (FNB) segment led the market in 2023.

5) Who are the key market players in the Global Endoscopic Ultrasound Needles Market?

Key players include Olympus Corporation, Cook Medical, Boston Scientific Corporation, CONMED, and Medi-Globe GmbH.